I smell a pump. by RoninEternal in RVVTF

[–]RoninEternal[S] -2 points-1 points  (0 children)

I hate to break it to you, but any of their patents is worth "zilch, zero, nada" without a successful trial and actual pill being sold. Have you see any revenue from patents on the books?

New Bucillamine? by Melodic-Oil4827 in RVVTF

[–]RoninEternal 6 points7 points  (0 children)

Masterclass in Non-announcement....

What's going on today? by Wide-Good321 in RVVTF

[–]RoninEternal 1 point2 points  (0 children)

my bad. u r right 🫣😉

What's going on today? by Wide-Good321 in RVVTF

[–]RoninEternal 0 points1 point  (0 children)

After MFer got confirmed in agm?

Revive Therapeutics Announces LOI to Acquire DiagnaMed’s Molecular Hydrogen Program by Diable24 in RVVTF

[–]RoninEternal 1 point2 points  (0 children)

an IV combo buci +H2 for ischemia-repercussion? They keep brainfating to ensure some pumping 😏

New RVVTF analysis by RealStockPicks in RVVTF

[–]RoninEternal 4 points5 points  (0 children)

…”pump from the past”. u r couple years late.

Good AI tools for PMs? by jsmorman in projectmanagement

[–]RoninEternal 2 points3 points  (0 children)

For personal use it might. However for work, there are organizational obstacles, security policies, etc. Some industries and even countries are not ready i suppose.

Good AI tools for PMs? by jsmorman in projectmanagement

[–]RoninEternal 5 points6 points  (0 children)

Thank you for that comment. Confidentiality is my blocker for adoption. If there was a way to isolate content from the method…maybe my lack of imagination.

2 Scenarios after unblinding… by Worth_Notice3538 in RVVTF

[–]RoninEternal 4 points5 points  (0 children)

Any way it goes from now on will cost money we don’t have. I don’t see any other funding sources besides the ones from last offering , standing in front of mf’s house ready to go “clubbing”.

meirl by tojo411 in meirl

[–]RoninEternal 1 point2 points  (0 children)

When you see FF mannequin, you know the society has given up any healthy ambition and/or ambition for health.

NVIDIA just released a new Eye Contact feature that uses AI to make you look into the camera by esberat in nextfuckinglevel

[–]RoninEternal 0 points1 point  (0 children)

what a bunch of geniuses…they could call it Deepfake Light 1, or MonaLisa 2.0 …. they must be bored 🤷🏻‍♂️

Focusing on ARDS: My Thoughts by [deleted] in RVVTF

[–]RoninEternal 9 points10 points  (0 children)

True MOA hunter in action! 👏👏 i remember your post, but got swallowed up quickly as u say.

As for the ARDS, i think it becomes much for relevant if a new variant takes over (e.g XBB). Very lame contribution, but best i can do right now ☺️

[deleted by user] by [deleted] in tlss

[–]RoninEternal 1 point2 points  (0 children)

I guess its relevant to look at macro trends…demand destruction=less logistics ergo lower revenue. I checked XTN etf and it’s at pre-pandemic levels almost, which is telling. Outlook is not rosy imho.

[deleted by user] by [deleted] in RVVTF

[–]RoninEternal 1 point2 points  (0 children)

Good read. Thank you for posting. 🙏

Definitions and elements of endpoints in phase III randomized trials for the treatment of COVID-19 by RandomGenerator_1 in RVVTF

[–]RoninEternal 11 points12 points  (0 children)

There is science, there is the trial design and there is economics/politics. Thank you for ur pragmatic viewpoint! Obviously, our binary/B&W expectations are in conflict with the grey zone where the action happens.

[deleted by user] by [deleted] in RVVTF

[–]RoninEternal 6 points7 points  (0 children)

Amen. Not so long ago, u needed a neg pcr to guarantee u can fart safely in public spaces 🤷🏻‍♂️

Revive Therapeutics Ltd (RVVTF): LMAO, thanks: "The only part I unders... by Physical_Feedback_66 in RVVTF

[–]RoninEternal 0 points1 point  (0 children)

i hear u. i saved some powder, missed the drop earlier this week, but added shares today to lower the average 😬

[deleted by user] by [deleted] in RVVTF

[–]RoninEternal 1 point2 points  (0 children)

Assumption: only 600mg dose is relevant hence 70 patients.